First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review
- PMID: 22898359
- DOI: 10.1016/j.contraception.2012.06.011
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review
Abstract
Background: The dose of mifepristone approved by most government agencies for medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and safety of regimens using the widely recommended lower mifepristone dose, 200 mg, followed by misoprostol in early pregnancy and to explore potential correlates of abortion failure.
Study design: To identify eligible reports, we searched Medline, reviewed reference lists of published reports, and contacted experts to identify all prospective trials of any design of medical abortion using 200 mg mifepristone followed by misoprostol in women with viable pregnancies up to 63 days' gestation. Two authors independently extracted data from each study. We used logistic regression models to explore associations between 15 characteristics of the trial groups and, separately, the rates of medical abortion failure and of ongoing pregnancy.
Results: We identified 87 trials that collectively included 120 groups of women treated with a regimen of interest. Of the 47,283 treated subjects in these groups, abortion outcome data were reported for 45,528 (96%). Treatment failure occurred in 2,192 (4.8%) of these evaluable subjects. Ongoing pregnancy was reported in 1.1% (499/45,150) of the evaluable subjects in the 117 trial groups reporting this outcome. The risk of medical abortion failure was higher among trial groups in which at least 25% of subjects had gestational age >8 weeks, the specified interval between mifepristone and misoprostol was less than 24 h, the total misoprostol dose was 400 mcg (rather than higher), or the misoprostol was administered by the oral route (rather than by vaginal, buccal, or sublingual routes). Across all trials, 119 evaluable subjects (0.3%) were hospitalized, and 45 (0.1%) received blood transfusions.
Conclusions: Early medical abortion with mifepristone 200 mg followed by misoprostol is highly effective and safe.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.Obstet Gynecol. 2015 Jul;126(1):12-21. doi: 10.1097/AOG.0000000000000897. Obstet Gynecol. 2015. PMID: 26241251 Review.
-
Medical methods for first trimester abortion.Cochrane Database Syst Rev. 2004;(1):CD002855. doi: 10.1002/14651858.CD002855.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3. PMID: 14973995 Updated. Review.
-
Medical methods for first trimester abortion.Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Nov 09;(11):CD002855. doi: 10.1002/14651858.CD002855.pub4. PMID: 15106180 Updated. Review.
-
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.Contraception. 2000 Jan;61(1):41-6. doi: 10.1016/s0010-7824(99)00119-5. Contraception. 2000. PMID: 10745068 Clinical Trial.
-
Medical methods for first trimester abortion.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2022 May 24;5:CD002855. doi: 10.1002/14651858.CD002855.pub5. PMID: 22071804 Free PMC article. Updated. Review.
Cited by
-
Abortion-pill challenge provokes doubt from US Supreme Court.Nature. 2024 Apr;628(8006):17-18. doi: 10.1038/d41586-024-00938-4. Nature. 2024. PMID: 38538891 No abstract available.
-
Association between previous surgical termination of pregnancy and pregnancy outcomes in frozen-thawed embryo transfer cycles of IVF/ICSI: a retrospective cohort study.Sci Rep. 2024 Mar 19;14(1):6579. doi: 10.1038/s41598-024-57377-4. Sci Rep. 2024. PMID: 38503837 Free PMC article.
-
Influential abortion-pill studies retracted: the science behind the decision.Nature. 2024 Feb 27. doi: 10.1038/d41586-024-00556-0. Online ahead of print. Nature. 2024. PMID: 38418730 No abstract available.
-
Effectiveness and safety of telehealth medication abortion in the USA.Nat Med. 2024 Apr;30(4):1191-1198. doi: 10.1038/s41591-024-02834-w. Epub 2024 Feb 15. Nat Med. 2024. PMID: 38361123 Free PMC article.
-
Medication Abortion Safety and Effectiveness With Misoprostol Alone.JAMA Netw Open. 2023 Oct 2;6(10):e2340042. doi: 10.1001/jamanetworkopen.2023.40042. JAMA Netw Open. 2023. PMID: 37889485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical